Cite
HARVARD Citation
Martin, C. et al. (2018). Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance. International journal of cancer. 142 (10), pp. 2139-2152. [Online].